The South Korean government will lift the requirement of wearing protective clothing for flight attendants on international routes from next month in an effort to hasten a return to normalcy for flights abroad.
The Ministry of Land, Infrastructure and Transport intends to notify airlines shortly about the recommendations for relaxing COVID-19 restrictions on overseas flights.
Beginning April 2020, South Korean airlines have required international flight crews to wear gloves and protective suits over their uniforms before passengers board.
International flight attendants were also obliged to wear goggles while traveling to locations with a high frequency of COVID-19 infections. After the planes land, the protective garments are discarded onboard.
Airline cabins have also been disinfected before each journey. The government intends to reduce cabin disinfection frequency to twice a month, a level seen prior to the outbreak.
Airlines have also been burdened by the expense of specific chemicals required to sanitize cabins before the flight, as well as added personnel expenditures.
Meanwhile, the issue of fairness has arisen since the disinfection methods for international flights are more stringent than those for domestic flights and public transportation such as buses, subways, and trains.


Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Columbia Student Mahmoud Khalil Fights Arrest as Deportation Case Moves to New Jersey
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Stuck in a creativity slump at work? Here are some surprising ways to get your spark back
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Debate over H-1B visas shines spotlight on US tech worker shortages 



